TrovaGene, Inc. (TROV) financial statements (2020 and earlier)

Company profile

Business Address 11055 FLINTKOTE AVENUE
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1011838672726
Cash and cash equivalents1011814672726
Short-term investments   24   
Receivables0000000
Other undisclosed current assets1111100
Total current assets:1113939682826
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment1124311
Other noncurrent assets0001000
Total noncurrent assets:2135311
TOTAL ASSETS:13141244712927
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4225332
Accounts payable1111110
Accrued liabilities3214222
Debt1 12520
Deferred revenue and credits000   
Total current liabilities:5348842
Noncurrent Liabilities
Long-term debt and lease obligation, including:1  1411130
Long-term debt, excluding current maturities   11  
Operating lease, liability1
Other undisclosed long-term debt and lease obligation   1310130
Liabilities, other than long-term debt0122334
Deferred revenue and credits111   
Other liabilities0      
Derivative instruments and hedges, liabilities0011334
Total noncurrent liabilities:1121615165
Total liabilities:6462423217
Stockholders' equity
Stockholders' equity attributable to parent, including:71072049820
Preferred stock0000000
Common stock0000000
Additional paid in capital2172021801681589087
Accumulated other comprehensive loss   (0)   
Accumulated deficit(209)(192)(173)(148)(109)(81)(67)
Other undisclosed stockholders' equity attributable to parent(1)      
Total stockholders' equity:71072049820
TOTAL LIABILITIES AND EQUITY:13141244712927

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0010000
Revenue, net010000
Sublease income0
Cost of revenue (1)(2)(2)(1)(0) 
Gross profit:0(0)(1)(1)(0)00
Operating expenses(17)(17)(26)(41)(26)(15)(11)
Other undisclosed operating income 122100
Operating loss:(17)(17)(26)(40)(25)(15)(11)
Nonoperating income
(Investment Income, Nonoperating)
000 000
Interest and debt expense (0)(3) (2)(1)(0)
Net loss:(16)(17)(28)(40)(27)(16)(11)
Other undisclosed net income (loss) attributable to parent0031(1)1(1)
Net loss attributable to parent:(16)(16)(25)(39)(27)(14)(12)
Preferred stock dividends and other adjustments(0)(0)(0)(0)(0)(0)(0)
Other undisclosed net loss available to common stockholders, basic(0)(3)     
Net loss available to common stockholders, basic:(17)(19)(25)(39)(27)(14)(12)
Other undisclosed net loss available to common stockholders, diluted   (2)(4)(2) 
Net loss available to common stockholders, diluted:(17)(19)(25)(42)(32)(17)(12)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(16)(17)(28)(40)(27)(16)(11)
Other comprehensive income  0    
Comprehensive loss:(16)(17)(28)(40)(27)(16)(11)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (2)3    
Comprehensive loss, net of tax, attributable to parent:(16)(19)(25)(40)(27)(16)(11)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: